Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-α.

Raso GM, Esposito E, Vitiello S, Iacono A, Santoro A, D'Agostino G, Sasso O, Russo R, Piazza PV, Calignano A, Meli R.

J Neuroendocrinol. 2011 Jul;23(7):591-600. doi: 10.1111/j.1365-2826.2011.02152.x.

PMID:
21554431
2.

Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis.

Sasso O, La Rana G, Vitiello S, Russo R, D'Agostino G, Iacono A, Russo E, Citraro R, Cuzzocrea S, Piazza PV, De Sarro G, Meli R, Calignano A.

Eur Neuropsychopharmacol. 2010 Mar;20(3):195-206. doi: 10.1016/j.euroneuro.2009.09.003. Epub 2009 Oct 27.

PMID:
19864116
3.

Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain.

Sasso O, Russo R, Vitiello S, Raso GM, D'Agostino G, Iacono A, Rana GL, Vallée M, Cuzzocrea S, Piazza PV, Meli R, Calignano A.

Pain. 2012 Jan;153(1):33-41. doi: 10.1016/j.pain.2011.08.010. Epub 2011 Sep 3.

PMID:
21890273
4.

Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis In Vitro.

Cipriano M, Esposito G, Negro L, Capoccia E, Sarnelli G, Scuderi C, De Filippis D, Steardo L, Iuvone T.

CNS Neurol Disord Drug Targets. 2015;14(7):828-37.

PMID:
25801844
5.

Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice.

D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, Raso GM, Cuzzocrea S, Lo Verme J, Piomelli D, Meli R, Calignano A.

J Pharmacol Exp Ther. 2007 Sep;322(3):1137-43. Epub 2007 Jun 12.

6.

The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.

Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D.

Mol Pharmacol. 2005 Jan;67(1):15-9. Epub 2004 Oct 1.

7.

Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity.

de Novellis V, Luongo L, Guida F, Cristino L, Palazzo E, Russo R, Marabese I, D'Agostino G, Calignano A, Rossi F, Di Marzo V, Maione S.

Eur J Pharmacol. 2012 Feb 15;676(1-3):41-50. doi: 10.1016/j.ejphar.2011.11.034. Epub 2011 Dec 3.

PMID:
22178921
8.

A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.

Leisewitz AV, Urrutia CR, Martinez GR, Loyola G, Bronfman M.

J Cell Physiol. 2008 Nov;217(2):367-76. doi: 10.1002/jcp.21509.

PMID:
18543250
9.
10.

Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.

D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, Mattace Raso G, Cuzzocrea S, Loverme J, Piomelli D, Meli R, Calignano A.

Eur J Pharmacol. 2009 Jun 24;613(1-3):54-9. doi: 10.1016/j.ejphar.2009.04.022. Epub 2009 Apr 20.

11.

Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice.

Di Paola R, Impellizzeri D, Mondello P, Velardi E, Aloisi C, Cappellani A, Esposito E, Cuzzocrea S.

Shock. 2012 Oct;38(4):356-66.

PMID:
22772472
12.

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.

Scuderi C, Valenza M, Stecca C, Esposito G, Carratù MR, Steardo L.

J Neuroinflammation. 2012 Mar 9;9:49. doi: 10.1186/1742-2094-9-21.

13.

Tetrahydrobiopterin biosynthesis in C6 glioma cells: induction of GTP cyclohydrolase I gene expression by lipopolysaccharide and cytokine treatment.

D'Sa C, Hirayama K, West A, Hahn M, Zhu M, Kapatos G.

Brain Res Mol Brain Res. 1996 Sep 5;41(1-2):105-10.

PMID:
8883940
14.

Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.

Koch M, Kreutz S, Böttger C, Benz A, Maronde E, Ghadban C, Korf HW, Dehghani F.

Neurotox Res. 2011 Feb;19(2):330-40. doi: 10.1007/s12640-010-9166-2. Epub 2010 Mar 11.

PMID:
20221904
15.

Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide.

Scuderi C, Esposito G, Blasio A, Valenza M, Arietti P, Steardo L Jr, Carnuccio R, De Filippis D, Petrosino S, Iuvone T, Di Marzo V, Steardo L.

J Cell Mol Med. 2011 Dec;15(12):2664-74. doi: 10.1111/j.1582-4934.2011.01267.x.

16.

Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha.

LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, Meli R, Hohmann A, Calignano A, Piomelli D.

J Pharmacol Exp Ther. 2006 Dec;319(3):1051-61. Epub 2006 Sep 22.

17.

The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes.

Kim HN, Lee SJ, Koh JY.

Neurochem Int. 2012 Jan;60(2):125-33. doi: 10.1016/j.neuint.2011.11.015. Epub 2011 Dec 1.

PMID:
22154800
18.

Palmitoylethanolamide in CNS health and disease.

Mattace Raso G, Russo R, Calignano A, Meli R.

Pharmacol Res. 2014 Aug;86:32-41. doi: 10.1016/j.phrs.2014.05.006. Epub 2014 May 17. Review.

PMID:
24844438
20.

Evidence for a new human CYP1A1 regulation pathway involving PPAR-alpha and 2 PPRE sites.

Sérée E, Villard PH, Pascussi JM, Pineau T, Maurel P, Nguyen QB, Fallone F, Martin PM, Champion S, Lacarelle B, Savouret JF, Barra Y.

Gastroenterology. 2004 Nov;127(5):1436-45.

PMID:
15521013

Supplemental Content

Support Center